Is a Single Dose of Doxycycline Enough? A Closer Look at Lyme Prophylaxis

Recently, I have been expanding my knowledge of vector-borne illnesses, including Lyme disease and other bacterial infections.

Current recommendations for prophylactic antibiotic use after a tick bite are largely dictated by the Centers for Disease Control and Prevention.1 These guidelines recommend a single high dose of doxycycline—a one-time antibiotic dose—under a fairly narrow set of criteria.

Those criteria include:

• The tick bite occurred in an area with a high prevalence of Borrelia burgdorferi

• The tick was removed within 72 hours

• The tick was engorged (not flat)

• The tick is identified as a blacklegged tick, formerly called the deer tick (Ixodes species)

At first glance, this seems reasonable. In practice, there are several problems with this model.

Second from the left is an Ixodes nymph. Photo credit: Centers for Disease Control and Prevention.

Problem #1: Geographic assumptions are flawed

The CDC relies heavily on maps that suggest certain regions—particularly parts of the Southeast, such as Georgia, South Carolina, and Florida—are “low risk.” This is misleading. Lyme disease has now been reported in all 50 states. When you compare tick distribution maps to Lyme reporting, there is a clear mismatch. The blacklegged tick, Ixodes scapularis, is widely distributed throughout the eastern United States, and other Ixodes species exist globally. The data strongly suggest that Lyme disease is underreported, not absent, in many regions.

Image credit: Colorado State University

Colorado State University’s map of Ixodes species is based on more than 16,000 samples submitted by the public for testing.2 Notably, the distribution of Ixodes ticks is far broader than the regions the CDC identifies as high risk for Lyme disease, as shown in the map below.

The CDC's Lyme disease incidence map is problematic because cases have been documented in all 50 states. Further, the distribution of the blacklegged tick is vast.

Problem #2: Tick identification is unrealistic

The CDC recommendation assumes that:

1. The tick is seen

2. The tick is correctly identified

In reality, most Lyme transmission occurs from nymph-stage ticks, which are extremely small, about the size of a poppy seed, and are often transparent. Most people will never see them. A nymph may also never appear engorged.

Expecting accurate identification of a blacklegged tick in real time is not practical in clinical or real-world settings. To the CDC's credit, they do state that prophylaxis "can still be considered when the tick cannot be identified."

Problem #3: Timing of transmission is not absolute

Older teaching suggested that ticks must be attached for 24–48 hours for transmission to occur. The timing is based on the amount of time for the gut contents of a tick to move to the tick's salivary glands, and then to the host. This is still commonly cited. However, animal models have demonstrated transmission of Borrelia burgdorferi as early as 12 hours, and in some cases, possibly sooner.3 This is particularly relevant for nymph-stage ticks, which may transmit more efficiently and sooner. Nymphs will often attach, detach, and reattach repeatedly, feeding each time. So while the risk increases with duration of attachment, it is not zero in the early period.

Problem #4: Engorgement is a risk factor—not a requirement

The CDC emphasizes that prophylaxis should be considered only if the tick is engorged.

Even their own schematics state that "Infection risk is higher with engorgement" and not that transmission is impossible without it. Despite this, the recommendation to withhold prophylaxis if the tick is flat is not entirely consistent with the underlying data. A flat appearing adult tick may, in fact, be a nymph, which causes most cases of Borrelia transmission.

Problem #5: A single dose may not be adequate

The recommendation for a single dose of doxycycline assumes that this level of early intervention is sufficient. In the 2021 study cited by the CDC to support this recommendation, 10 cases of Lyme disease were reported among 1,041 participants (approximately 1%) who received prophylactic doxycycline. In the untreated group, 19 cases occurred among 648 participants (approximately 3%).4

This reduction—from 3% to 1%—is presented in the study as a 67% relative risk reduction.4 However, when viewed in absolute terms, the reduction by 2%. Put another way, among the three individuals expected to develop Lyme disease, prophylaxis would prevent infection in approximately two, meaning that only about one in three individuals at risk would benefit from the single-dose approach. 1/3 of people who take a single prophylactic dose would still develop Lyme disease.

A study evaluating cerebrospinal fluid from 12 patients with early disseminated Lyme disease (within approximately 2 weeks of a tick bite) found that Borrelia burgdorferi DNA was present in the CNS of 8 patients.5 Of the 8, only 4 had neurologic symptoms.5 These patients were compared to 16 unsymptomatic controls, none of whom had Borrelia burgdorferi DNA in their CNS. This suggests CNS involvement can occur early and be asymptomatic initially.5

Current treatment recommendations for neuroborreliosis involve weeks of antibiotics, not a single dose. If dissemination—including to the central nervous system—can occur early, then a one-time dose raises legitimate questions about adequacy. Considering that Borrelia is a mobile bacterium with a spiral shape and flagella that allow it to swim and burrow, it is not surprising that it may distribute itself rapidly throughout the host and do so early.

Bottom line

The current CDC prophylaxis model is:

• Narrow

• Conservative

• Based on assumptions that may not reflect real-world exposure

It relies on:

• Geographic risk that is likely underestimated

• Tick identification is often unrealistic

• Timing assumptions that are not absolute

• A treatment strategy that may be insufficient in early dissemination

Clinical judgment should not be replaced by rigid criteria, and it appears that the Centers for Disease Control and Prevention acknowledges this in its guidance, which frames each step as part of an assessment rather than an absolute requirement for prophylaxis.

Resources:

1. https://www.cdc.gov/lyme/resources/pdfs/lyme-pep-low-ink-p.pdf

2. https://natsci.source.colostate.edu/who-got-bit-by-mailing-in-16000-ticks-citizen-scientists-help-track-disease-exposures/

3. https://www.pasteur.fr/en/research-journal/news/lyme-disease-study-speed-transmission-infected-ticks

4. Harms MG, Hofhuis A, Sprong H, Bennema SC, Ferreira JA, Fonville M, Docters van Leeuwen A, Assendelft WJJ, Van Weert HCPM, Van Pelt W, Van den Wijngaard CC. A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trial. J Infect. 2021 Jan;82(1):98-104. doi: 10.1016/j.jinf.2020.06.032. Epub 2020 Jun 18. PMID: 32565073.

5. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, Kunkel M, Dattwyler RJ. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992 Mar 11;267(10):1364-7. Erratum in: JAMA 1992 Aug 19;268(7):872. PMID: 1740859.